Evolution of the Average Target: Clarivate Plc

Evolution of the Target Price: Clarivate Plc

Changes in Analyst Recommendations: Clarivate Plc

b6ad.QzQP05J1aAKTzRBeYR9VNjfbeRo-ZAJibNBsyDjBKvU.CgZbh90_BWf4gz09N1YkV2eNS3IPUEUxNegIhAGtE5MsRVfqo01ba8meYw~db4995925289e92805087f81bb1b8a3a
29/04 Clarivate Faces Q1 Segment Headwinds While Advancing Value Creation Plan, RBC Says MT
26/02 RBC Capital Adjusts Clarivate Price Target to $3 From $5, Maintains Sector Perform Rating MT
25/02 Analyst recommendations: IBM, Axon, Caterpillar, Fair Isaac, Gilead… Zonebourse
08/01 Goldman Sachs Downgrades Clarivate to Neutral From Buy, Adjusts Price Target to $3.60 From $4.20 MT
08/01 Analyst recommendations: Alphabet, Chubb, Ford, Stellantis, The Gap… Zonebourse
17/12 Morgan Stanley Downgrades Clarivate to Underweight From Equal Weight, Adjusts PT to $3 From $5 MT
05/12 RBC Cuts Price Target on Clarivate to $5 From $6, Keeps Sector Perform Rating MT
29/10/25 (CLVT) Clarivate Expects 2025 Adjusted EPS Range $0.60 - $0.70, vs. FactSet Est of $0.65 MT
01/10/25 Clarivate Likely to Post In-Line Q3 Results, Reiterate FY25 Outlook, RBC Capital Says MT
03/09/25 Wolfe Research Initiates Clarivate at Peer Perform MT
19/07/25 Clarivate Shares Fall After Downgrade From Jefferies MT
18/07/25 Jefferies Downgrades Clarivate to Hold From Buy, Trims Price Target to $4.50 From $5.20 MT
09/04/25 Oppenheimer Adjusts Clarivate Price Target to $6 From $7, Maintains Outperform Rating MT
22/02/25 Global Investors Eye New Shores Zonebourse
21/02/25 Analyst recommendations: Alphabet, Lear Corp, Molson Coors, Hasbro, Visa... Zonebourse
08/11/24 Oppenheimer Adjusts Clarivate Price Target to $7 From $9, Maintains Outperform Rating MT
08/11/24 RBC Adjusts Clarivate's Price Target to $6 From $7, Keeps Sector Perform Rating MT
07/11/24 Analyst recommendations: Corteva, Dollar Tree, JPMorgan, Microsoft, Palantir... Zonebourse
07/11/24 William Blair Downgrades Clarivate to Market Perform From Outperform MT
07/08/24 RBC Cuts Price Target on Clarivate to $7 From $8, Keeps Sector Perform Rating MT
03/07/24 Oppenheimer Trims Price Target on Clarivate to $9 From $10, Maintains Outperform Rating MT
10/05/24 Goldman Sachs Adjusts Price Target on Clarivate to $7.50 From $8.50, Maintains Buy Rating MT
29/02/24 Barclays Trims Price Target on Clarivate to $6 From $7, Maintains Underweight Rating MT
29/02/24 Oppenheimer Trims Clarivate Price Target to $10 From $11, Maintains Outperform Rating MT
28/02/24 RBC Cuts Price Target on Clarivate to $8 From $10, Cites Limited Visibility on Second-Half Turnaround; Sector Perform Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +7.76%
+17%
+14.04%
+34.31%
+31.59%
-3.77%
+49.69%
+19.02%
+0.55%
+12.71%
Average +18.29%
Weighted average by Cap. +19.98%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
2.320USD
Average target price
2.500USD
Spread / Average Target
+7.76%
High Price Target
2.500USD
Spread / Highest target
+7.76%
Low Price Target
2.500USD
Spread / Lowest Target
+7.76%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

RBC Capital Markets
Goldman Sachs
Morgan Stanley
Wolfe Research
Jefferies & Co.
Oppenheimer
William Blair & Co.
Barclays
Wells Fargo Securities
Citigroup
BofA Securities
Stifel Nicolaus
B. Riley
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
2.320USD
Average target price
2.500USD
Spread / Average Target
+7.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CLVT Stock
  4. Consensus Clarivate Plc